IGHG1 and prostate carcinoma: We have revealed the presence of cytoplasmic and membranous IGHG1 in prostate cancer cell lines (LNCaP, PC3) previously and found that inhibition of IGHG1 by siRNA approach suppressed cell proliferation and induced apoptosis [12].